Creon DR 36,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DB25FK3ZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,656
Award facts
- Contract value 100% obligated
- $4,656.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,656.29 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement therapy. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical federal medical procurement vendor, supplying a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's portfolio of federal contract awards demonstrates extensive experience fulfilling Defense Logistics Agency requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The Pharmaceutical Prime Vendor Global Program vehicle under which this delivery order falls enables AmerisourceBergen to support customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key supplier within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FK3ZT?
SPE2DB25FK3ZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FK3ZT worth?
The government has obligated $4,656 on SPE2DB25FK3ZT.
Is contract SPE2DB25FK3ZT an order under another contract?
Yes. SPE2DB25FK3ZT is a delivery order under SPE2DB22D3019, an indefinite delivery contract.
Was contract SPE2DB25FK3ZT competed?
The extent of competition for SPE2DB25FK3ZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award